Evidence map›Paper›PMID 40319095›Full record

ArticleScientific reports2025

Genetic feature selection algorithm as an efficient glioma grade classifier.

Ting-Han Lin, Hung-Yi Lin

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ting-Han Lin *China Medical University Hospital, No. 2, Yude Rd., North Dist., Taichung City, 404327, Taiwan. 101078@tool.caaumed.org.tw.
Hung-Yi Lin *Department of Distribution Management, National Taichung University of Science and Technology, 129, Sanmin Rd., Sec. 3, Taichung, Taiwan (R.O.C.). linhy@nutc.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliomas are among the most lethal and debilitating cancers. Genetic testing is a rapidly evolving modality for cancer management. The advent of DNA microarrays enabled the utility of computational analyses in such management on a molecular basis. However, as current computational analyses remain insensitive to interactions between molecular features, they rarely postulate reasonable pathogenesis. The current study proposes a heuristic feature selection algorithm that identifies subsets of genes to almost perfectly classify glioma grades. The discretization technique in our method is a powerful tool against the tremendous data volume in DNA microarray. Instead of recognizing individual genetic features, the proposed algorithm helps identify specific gene subsets that play important roles in the pathogenesis of glioma.

Indexed as

AlgorithmsBrain NeoplasmsGliomaComputational BiologyGene Expression ProfilingHumansNeoplasm GradingOligonucleotide Array Sequence AnalysisClassification efficiencyComputational analysisDiscretizationGene selectionGenetic testingGliomaHeuristic feature selectionMolecular analysis

Identifiers

PMID40319095
PMCPMC12049469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.